Ganglioneuroblastoma Clinical Trials in Moscow
3 recruitingMoscow, Russia
Showing 1–3 of 3 trials
Recruiting
Phase 3
Chemoimmunotherapy Combined With Autologous NK Cell Therapy for Pediatric Patients With Refractory and Relapsed High-Risk Neuroblastoma and Ganglioneuroblastoma
Neuroblastoma (NB)Ganglioneuroblastoma
Federal Research Institute of Pediatric Hematology, Oncology and Immunology5 enrolled1 locationNCT07375563
Recruiting
Abdominal Neuroblastoma Laparoscopic Surgery Risk Factors Stratification
NeuroblastomaGanglioneuromaGanglioneuroblastoma
Federal Research Institute of Pediatric Hematology, Oncology and Immunology200 enrolled1 locationNCT06296732
Recruiting
Phase 3
Induction Chemoimmunotherapy for Patients With High-risk Neuroblastoma
NeuroblastomaGanglioneuroblastoma
Federal Research Institute of Pediatric Hematology, Oncology and Immunology15 enrolled1 locationNCT06071897